ABBV · Earnings call · 2026Q3T · Full report

Macroeconomic Consumer Pressure

AbbVie Inc. · 2026-10-30 · Importance 16 · Surprise 24

Management said economic uncertainty and lower consumer confidence had pressured the aesthetics category over the preceding several quarters. AbbVie reported early signs of stability and identified the rollout of Boey, a fast-acting, short-duration toxin, as an opportunity to encourage new patients to begin aesthetic treatments. The commercial rollout was underway in Europe and Canada.

Key facts

• AbbVie said economic uncertainty and lower consumer confidence have pressured the aesthetics category over the last several quarters, although it is seeing signs of stability.